Tridacaine Xl Patch
Product Images NDC 73352-845

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tridacaine Xl (NDC 73352-845). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trifluent Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tridacainexl 01)

Chemical structure of lidocaine, showing its aromatic ring with two methyl groups and the amide linkage to an ethyl-substituted amine group.*

FDA Label Image

Figure 1 (Tridacainexl 02)

A line graph showing plasma lidocaine concentration (ng/mL) over a 72-hour period. The x-axis shows time in hours, and the y-axis shows plasma lidocaine levels. The graph displays a repeating peak and trough pattern, indicating fluctuations in lidocaine concentration in plasma over time.*

FDA Label Image

Principal Display Panel (30 Patch Box Label)

Label for Tridacaine XL Lidocaine Patch 5%, a topical prescription drug by Trifluent Pharma LLC. The label states each adhesive patch contains 700 mg lidocaine USP (50 mg/g adhesive). It lists inactive ingredients, storage instructions (20° to 25°C), a warning to keep patches away from children and pets, and packaging details of 30 patches in 30 envelopes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.